We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+11.85%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$41.8B
AUM Growth
+$1.48B
(+3.7%)
Cap. Flow
-$1.36B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
19.13%
Holding
1,140
New
93
Increased
265
Reduced
373
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chipotle Mexican Grill
CMG
|
+$197M |
| 2 |
Occidental Petroleum
OXY
|
+$124M |
| 3 |
Boeing
BA
|
+$111M |
| 4 |
argenx
ARGX
|
+$108M |
| 5 |
CMA
Comerica
CMA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$349M |
| 2 |
Burlington
BURL
|
+$186M |
| 3 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$166M |
| 4 |
Textron
TXT
|
+$160M |
| 5 |
Honeywell
HON
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.51% |
| 2 | Healthcare | 18.38% |
| 3 | Financials | 16.37% |
| 4 | Industrials | 8.21% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Akamai
AKAM
$17.2B
| $13.5M | 0.03% |
159,900
-2,000
| -1% | -$174K |
|
552
LanzaTech
LNZA
$68M
| $13.5M | 0.03% |
13,500
| – | – |
|
|
NKGN
553
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $13.4M | 0.03% |
1,350,000
| – | – |
|
554
Borealis Foods
BRLS
$17.6M
| $13.4M | 0.03% |
1,300,000
| – | – |
|
555
Doximity
DOCS
$3.77B
| $13.4M | 0.03% |
+400,000
| New | +$12.2M |
|
556
ProQR Therapeutics
PRQR
$268M
| $13.4M | 0.03% |
3,625,467
+325,467
| +10% | +$426K |
|
557
Expedia Group
EXPE
$36.8B
| $13.4M | 0.03% |
153,100
-1,800
| -1% | -$170K |
|
|
VERV
558
DELISTED
Verve Therapeutics
VERV
| $13.4M | 0.03% |
690,000
+150,000
| +28% | +$3.97M |
|
559
Bio-Rad Laboratories Class A
BIO
$9.16B
| $13.2M | 0.03% |
31,475
-39,900
| -56% | -$16.1M |
|
|
ACLX
560
DELISTED
Arcellx
ACLX
| $13.2M | 0.03% |
426,904
-100,000
| -19% | -$2.29M |
|
561
CBRE Group
CBRE
$42.7B
| $13.2M | 0.03% |
171,400
-80,800
| -32% | -$5.97M |
|
|
IPG
562
DELISTED
Interpublic Group of Companies
IPG
| $13.2M | 0.03% |
395,189
-3,200
| -0.8% | -$99.3K |
|
563
Lamb Weston
LW
$7.16B
| $13.1M | 0.03% |
146,300
-100
| -0.1% | -$8.51K |
|
564
Verisk Analytics
VRSK
$24.7B
| $13.1M | 0.03% |
74,100
-800
| -1% | -$141K |
|
565
Nordson
NDSN
$17.2B
| $13M | 0.03% |
54,700
-400
| -0.7% | -$91.3K |
|
566
PTC
PTC
$16B
| $12.9M | 0.03% |
107,500
-200
| -0.2% | -$23.9K |
|
567
Wabtec
WAB
$49.9B
| $12.8M | 0.03% |
128,321
+24,700
| +24% | +$2.36M |
|
|
BRD
568
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $12.7M | 0.03% |
1,250,000
| – | – |
|
569
Extra Space Storage
EXR
$31.6B
| $12.7M | 0.03% |
86,200
-25,200
| -23% | -$4.03M |
|
570
Aflac
AFL
$64.5B
| $12.6M | 0.03% |
+175,474
| New | +$11.7M |
|
|
SDAC
571
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
| $12.6M | 0.03% |
1,250,000
| – | – |
|
|
CERE
572
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $12.6M | 0.03% |
398,520
| – | – |
|
573
Otis Worldwide
OTIS
$28.1B
| $12.6M | 0.03% |
+160,424
| New | +$11.8M |
|
574
Axcelis
ACLS
$4.2B
| $12.5M | 0.03% |
158,000
-95,000
| -38% | -$6.69M |
|
575
United Airlines
UAL
$41.9B
| $12.5M | 0.03% |
332,509
+250,700
| +306% | +$10.2M |
|
Similar funds
Adage Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Adage Capital Partners held 1,140 positions worth $41.8B, up 3.7% from $40.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Adage Capital Partners withdrew a net $1.36B in Q4 2022, closing 166 positions and reducing 373 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $349M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in argenx worth $109M.
- Adage Capital Partners's largest Q4 2022 buy was argenx: 287,396 shares worth $109M.
- Adage Capital Partners added most to Chipotle Mexican Grill in Q4 2022, an estimated $197M increase.
- Adage Capital Partners's biggest Q4 2022 reduction was Burlington, cutting an estimated $186M.
- Adage Capital Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $349M.
- Adage Capital Partners's ten largest holdings make up 19% of its $41.8B portfolio in Q4 2022.
- Adage Capital Partners opened 93 new positions and closed 166 in Q4 2022.
- Adage Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $41.8B.
Based on Adage Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.